Doctorglasses Chain Co.,Ltd.

SZSE:300622 Stock Report

Market Cap: CN¥4.7b

Doctorglasses ChainLtd Future Growth

Future criteria checks 1/6

Doctorglasses ChainLtd is forecast to grow earnings and revenue by 15.2% and 10.8% per annum respectively. EPS is expected to grow by 15.3% per annum. Return on equity is forecast to be 18.1% in 3 years.

Key information

15.2%

Earnings growth rate

15.3%

EPS growth rate

Medical Equipment earnings growth23.8%
Revenue growth rate10.8%
Future return on equity18.1%
Analyst coverage

Low

Last updated02 Sep 2024

Recent future growth updates

No updates

Recent updates

Investors Will Want Doctorglasses ChainLtd's (SZSE:300622) Growth In ROCE To Persist

Oct 02
Investors Will Want Doctorglasses ChainLtd's (SZSE:300622) Growth In ROCE To Persist

Some Confidence Is Lacking In Doctorglasses Chain Co.,Ltd. (SZSE:300622) As Shares Slide 27%

Sep 15
Some Confidence Is Lacking In Doctorglasses Chain Co.,Ltd. (SZSE:300622) As Shares Slide 27%

Estimating The Fair Value Of Doctorglasses Chain Co.,Ltd. (SZSE:300622)

Aug 28
Estimating The Fair Value Of Doctorglasses Chain Co.,Ltd. (SZSE:300622)

Investors Appear Satisfied With Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Prospects As Shares Rocket 38%

Jul 30
Investors Appear Satisfied With Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Prospects As Shares Rocket 38%

Solid Earnings Reflect Doctorglasses ChainLtd's (SZSE:300622) Strength As A Business

Apr 09
Solid Earnings Reflect Doctorglasses ChainLtd's (SZSE:300622) Strength As A Business

Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Shares Bounce 28% But Its Business Still Trails The Market

Mar 07
Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Shares Bounce 28% But Its Business Still Trails The Market

Earnings and Revenue Growth Forecasts

SZSE:300622 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,552169N/A2842
12/31/20251,400146N/A1982
12/31/20241,272129N/A2442
6/30/20241,178114224246N/A
3/31/20241,162116228251N/A
12/31/20231,176128259281N/A
9/30/20231,137125285305N/A
6/30/20231,104122261286N/A
3/31/20231,051106239265N/A
1/1/202396276182208N/A
9/30/202295678159192N/A
6/30/202292370154192N/A
3/31/202290680156197N/A
1/1/202288795171214N/A
9/30/2021873108167205N/A
6/30/2021818108166198N/A
3/31/202175896119146N/A
12/31/20206566976102N/A
9/30/2020613486097N/A
6/30/2020607434183N/A
3/31/2020605453987N/A
1/1/2020655624398N/A
9/30/2019631562778N/A
6/30/2019610581463N/A
3/31/201958960449N/A
12/31/201856659-437N/A
9/30/201853759234N/A
6/30/2018508571240N/A
3/31/201848755N/A47N/A
12/31/201747152N/A62N/A
9/30/201745749N/A77N/A
6/30/201744042N/A71N/A
3/31/201743141N/A72N/A
12/31/201641638N/A67N/A
3/31/201638737N/A65N/A
12/31/201537635N/A48N/A
12/31/201436134N/A57N/A
12/31/201332833N/A18N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300622's forecast earnings growth (15.2% per year) is above the savings rate (2.9%).

Earnings vs Market: 300622's earnings (15.2% per year) are forecast to grow slower than the CN market (23.7% per year).

High Growth Earnings: 300622's earnings are forecast to grow, but not significantly.

Revenue vs Market: 300622's revenue (10.8% per year) is forecast to grow slower than the CN market (13.5% per year).

High Growth Revenue: 300622's revenue (10.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300622's Return on Equity is forecast to be low in 3 years time (18.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y